KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Long-Term Investments (2018 - 2025)

Historic Long-Term Investments for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $304.2 million.

  • Vir Biotechnology's Long-Term Investments rose 1205.07% to $304.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $304.2 million, marking a year-over-year increase of 1205.07%. This contributed to the annual value of $190.0 million for FY2024, which is 8049.39% up from last year.
  • Per Vir Biotechnology's latest filing, its Long-Term Investments stood at $304.2 million for Q3 2025, which was up 1205.07% from $286.1 million recorded in Q2 2025.
  • Over the past 5 years, Vir Biotechnology's Long-Term Investments peaked at $359.7 million during Q1 2024, and registered a low of $5.7 million during Q2 2021.
  • Its 5-year average for Long-Term Investments is $154.3 million, with a median of $105.3 million in 2023.
  • The largest annual percentage gain for Vir Biotechnology's Long-Term Investments in the last 5 years was 161201.75% (2022), contrasted with its biggest fall of 8811.9% (2022).
  • Vir Biotechnology's Long-Term Investments (Quarter) stood at $201.4 million in 2021, then crashed by 88.12% to $23.9 million in 2022, then soared by 339.98% to $105.3 million in 2023, then surged by 80.49% to $190.0 million in 2024, then skyrocketed by 60.1% to $304.2 million in 2025.
  • Its Long-Term Investments was $304.2 million in Q3 2025, compared to $286.1 million in Q2 2025 and $218.1 million in Q1 2025.